Extracorporeal shock wave lithotripsy is safe and effective for geriatric patients with chronic pancreatitis. Issue 2 (4th January 2019)

• Record Type: Journal Article
• Authors: Hao, Lu; Liu, Yu; Wang, Teng; Guo, Hong‐Lei; Wang, Dan; Bi, Ya‐Wei; Xin, Lei; He, Lin; Lin, Jin‐Huan; Zhang, Di; Zeng, Xiang‐Peng; Zou, Wen‐Bin; Chen, Hui; Xie, Ting; Li, Bai‐Rong; Cong, Zhi‐Jie; Wang, Li‐Sheng; Liao, Zhuan; Xu, Zheng‐Lei; Li, Zhao‐Shen; Hu, Liang‐Hao
• Is Part Of: Journal of gastroenterology and hepatology. Volume 34:Issue 2(2019)
• Page Start: 466
• Page End: 473
• Publication Date: 2019-01-04
• Subjects: chronic pancreatitis -- extracorporeal shock wave lithotripsy -- geriatric; Gastroenterology -- Periodicals; Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; Gastroenterology -- Periodicals; Liver Diseases -- Periodicals; 616.33
• DOI: 10.1111/jgh.14569
• Languages: English
• ISSNs: 0815-9319

Abstract

Abstract: Background and Aim: Pancreatic extracorporeal shock wave lithotripsy (P‐ESWL) is a first‐line treatment for chronic pancreatitis (CP) patients with pancreatic stones. However, the performance of P‐EWSL in geriatric patients remains unclear. We aimed to evaluate the safety and efficacy of P‐ESWL for them. Methods: This prospective study was conducted in painful CP patients who underwent P‐ESWL. Patients aged over 65 years were included in geriatric group; patients aged under 65 years were assigned to control group. For the long‐term follow‐up investigation, geriatric patients were matched with patients from the control group in a 1:1 ratio. Primary outcomes were complications of P‐ESWL and pain relief. Secondary outcomes included stone clearance, physical and mental health, quality of life score, changes in exocrine and endocrine pancreatic function, and survival. Results: From March 2011 to March 2016, P‐ESWL was performed in 1404 patients (72 in the geriatric group and 1332 in the control group). No significant differences were observed in complications of P‐ESWL between the two groups ( P = 0.364). Among the 67 (67/72, 93.1%) geriatric patients who underwent follow up for 4.02 years, complete pain relief was achieved in 53 patients, which was not significantly different from that of matched controls (54/70; P = 0.920). The death in the geriatrics was significantly higher ( P = 0.007), but none of them were correlated with P‐ESWL. Conclusions: P‐ESWL is safe and effective for geriatric CP patients with pancreatic stones. It can promote significant pain relief and stone clearance and improve quality of life and mental and physical health.